N. Blanpain, Projections de population à l'horizon 2060 Un tiers de la population âgé de plus de 60 ans. INSEE Premiere, 2010.

A. Charlemagne, J. Blacher, A. Cohen, J. Collet, F. Diévart et al., Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data, Archives of Cardiovascular Diseases, vol.104, issue.2, pp.115-124, 2011.
DOI : 10.1016/j.acvd.2010.11.012

J. Mant, F. Hobbs, K. Fletcher, A. Roalfe, D. Fitzmaurice et al., Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial, The Lancet, vol.370, issue.9586, pp.493-503, 2007.
DOI : 10.1016/S0140-6736(07)61233-1

R. Nieuwlaat, M. Prins, L. Heuzey, J. Vardas, P. Aliot et al., Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation, European Heart Journal, vol.29, issue.9, pp.1181-1189, 2008.
DOI : 10.1093/eurheartj/ehn139

R. Nieuwlaat, S. Olsson, G. Lip, A. Camm, G. Breithardt et al., Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation, American Heart Journal, vol.153, issue.6, pp.1006-1012, 2007.
DOI : 10.1016/j.ahj.2007.03.008

E. Hylek, A. Go, Y. Chang, N. Jensvold, L. Henault et al., Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation, New England Journal of Medicine, vol.349, issue.11, pp.1019-1026, 2003.
DOI : 10.1056/NEJMoa022913

R. Hart, L. Pearce, and M. Aguilar, Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation, Annals of Internal Medicine, vol.146, issue.12, pp.857-867, 2007.
DOI : 10.7326/0003-4819-146-12-200706190-00007

G. Palareti and . Hj, Oral Anticoagulation Treatment in the Elderly, Archives of Internal Medicine, vol.160, issue.4, pp.470-478, 2000.
DOI : 10.1001/archinte.160.4.470

G. Palareti and B. Cosmi, Bleeding with anticoagulation therapy ??? Who is at risk, and how best to identify such patients, Thrombosis and Haemostasis, vol.102, issue.2, pp.268-278, 2009.
DOI : 10.1160/TH08-11-0730

D. Budnitz, M. Lovegrove, N. Shehab, and C. Richards, Emergency hospitalizations for adverse drug events in older Americans, N Engl J Med. 24 nov, vol.365, issue.21, 2011.

B. Gage, Y. Yan, P. Milligan, A. Waterman, R. Culverhouse et al., Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF), American Heart Journal, vol.151, issue.3, pp.713-719, 2006.
DOI : 10.1016/j.ahj.2005.04.017

R. Pisters, D. Lane, R. Nieuwlaat, C. De-vos, H. Crijns et al., A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation, Chest, vol.138, issue.5, pp.1093-1100, 2010.
DOI : 10.1378/chest.10-0134

A. Camm, P. Kirchhof, and G. Lip, Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors/Task Force Members Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Developed with the special contribution of the European Heart Rhythm Association (EHRA), pp.2369-2429, 2010.

L. Fried, C. Tangen, J. Walston, A. Newman, C. Hirsch et al., Frailty in Older Adults: Evidence for a Phenotype, The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol.56, issue.3, pp.146-156, 2001.
DOI : 10.1093/gerona/56.3.M146

A. Go, E. Hylek, K. Phillips, Y. Chang, L. Henault et al., Prevalence of Diagnosed Atrial Fibrillation in Adults, JAMA, vol.285, issue.18, pp.2370-2375, 2001.
DOI : 10.1001/jama.285.18.2370

J. Heeringa, D. Van-der-kuip, A. Hofman, J. Kors, G. Van-herpen et al., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, European Heart Journal, vol.27, issue.8, pp.949-953, 2006.
DOI : 10.1093/eurheartj/ehi825

B. Psaty, T. Manolio, L. Kuller, R. Kronmal, M. Cushman et al., Incidence of and Risk Factors for Atrial Fibrillation in Older Adults, Circulation, vol.96, issue.7, pp.2455-2461, 1997.
DOI : 10.1161/01.CIR.96.7.2455

C. Van-walraven, R. Hart, S. Connolly, P. Austin, J. Mant et al., Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators, Stroke, vol.40, issue.4, pp.1410-1416, 2009.
DOI : 10.1161/STROKEAHA.108.526988

O. Hanon, P. Assayag, J. Belmin, J. Collet, J. Emeriau et al., Expert consensus of the French Society of Geriatrics and Gerontology and the French Society of Cardiology on the management of atrial fibrillation in elderly people, Archives of Cardiovascular Diseases, vol.106, issue.5, pp.303-323, 2013.
DOI : 10.1016/j.acvd.2013.04.001

URL : https://hal.archives-ouvertes.fr/hal-00879721

S. Wolowacz, M. Samuel, V. Brennan, J. Jasso-mosqueda, V. Gelder et al., The cost of illness of atrial fibrillation: a systematic review of the recent literature. Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol, oct, vol.13, issue.10, pp.1375-1385, 2011.

B. Brüggenjürgen, K. Rossnagel, S. Roll, F. Andersson, D. Selim et al., The Impact of Atrial Fibrillation on the Cost of Stroke: The Berlin Acute Stroke Study, Value in Health, vol.10, issue.2, pp.137-143, 2007.
DOI : 10.1111/j.1524-4733.2006.00160.x

C. Lundqvist, G. Lip, and P. Kirchhof, What are the costs of atrial fibrillation? Europace. 5 janv, pp.9-12, 2011.

S. Ghate, J. Biskupiak, X. Ye, W. Kwong, and D. Brixner, All-Cause and Bleeding-Related Health Care Costs in Warfarin-Treated Patients with Atrial Fibrillation, Journal of Managed Care Pharmacy, vol.17, issue.9, pp.672-684, 2011.
DOI : 10.18553/jmcp.2011.17.9.672

R. Pisters, D. Lane, F. Marin, A. Camm, and G. Lip, Stroke and Thromboembolism in Atrial Fibrillation, Circulation Journal, vol.76, issue.10, pp.2289-2304, 2012.
DOI : 10.1253/circj.CJ-12-1036

S. Boccuzzi, J. Martin, J. Stephenson, C. Kreilick, J. Fernandes et al., Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed, Current Medical Research and Opinion, vol.25, issue.12
DOI : 10.1185/03007990903196422

A. Ott, M. Breteler, M. De-bruyne, F. Van-harskamp, D. Grobbee et al., Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study, Stroke, vol.28, issue.2, pp.316-321, 1997.
DOI : 10.1161/01.STR.28.2.316

M. Barber, R. Tait, J. Scott, A. Rumley, G. Lowe et al., Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation, Journal of Thrombosis and Haemostasis, vol.44, issue.17, pp.1873-1878, 2004.
DOI : 10.1046/j.1365-2141.1997.1222936.x

P. Santangeli, D. Biase, L. Bai, R. Mohanty, S. Pump et al., Atrial fibrillation and the risk of incident dementia: A meta-analysis, Heart Rhythm, vol.9, issue.11, pp.1761-1768, 2012.
DOI : 10.1016/j.hrthm.2012.07.026

A. Scowcroft, S. Lee, and J. Mant, Thromboprophylaxis of elderly patients with AF in the UK: an analysis using the General Practice Research Database, pp.2000-2009

P. Sinnaeve, M. Brueckmann, A. Clemens, J. Oldgren, J. Eikelboom et al., Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation, Journal of Internal Medicine, vol.298, issue.1, pp.15-24, 2012.
DOI : 10.1111/j.1365-2796.2011.02464.x

J. Segal, R. Mcnamara, M. Miller, N. Kim, and S. Goodman, Prevention of thromboembolism in atrial fibrillation, Journal of General Internal Medicine, vol.50, issue.10, pp.56-67, 2000.
DOI : 10.1046/j.1525-1497.2000.04329.x

D. Singer, Y. Chang, M. Fang, L. Borowsky, N. Pomernacki et al., The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation, Annals of Internal Medicine, vol.151, issue.5, pp.297-305, 2009.
DOI : 10.7326/0003-4819-151-5-200909010-00003

A. Rash, T. Downes, R. Portner, W. Yeo, N. Morgan et al., A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO), Age and Ageing, vol.36, issue.2, pp.151-156, 2007.
DOI : 10.1093/ageing/afl129

C. Van-walraven, R. Hart, and D. Singer, Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation, JAMA, vol.288, issue.19, pp.2441-2448, 2002.
DOI : 10.1001/jama.288.19.2441

L. Friberg, M. Rosenqvist, and G. Lip, Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study, European Heart Journal, vol.33, issue.12, pp.1500-1510, 2012.
DOI : 10.1093/eurheartj/ehr488

E. Hylek, C. Evans-molina, C. Shea, L. Henault, and S. Regan, Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation, Circulation, vol.115, issue.21, pp.2689-2696, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.653048

M. Fang, Y. Chang, E. Hylek, J. Rosand, S. Greenberg et al., Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation, Annals of Internal Medicine, vol.141, issue.10, pp.745-752, 2004.
DOI : 10.7326/0003-4819-141-10-200411160-00005

T. Gomes, M. Mamdani, A. Holbrook, J. Paterson, C. Hellings et al., Rates of hemorrhage during warfarin therapy for atrial fibrillation, Canadian Medical Association Journal, vol.185, issue.2, pp.121-127, 2012.
DOI : 10.1503/cmaj.121218

A. Gentric and S. Estivin, Use of anticoagulant treatments in the elderly. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, juin, vol.27, issue.6, pp.458-464, 2006.

M. Fang, A. Go, E. Hylek, Y. Chang, L. Henault et al., Age and the Risk of Warfarin-Associated Hemorrhage: The Anticoagulation and Risk Factors In Atrial Fibrillation Study, Journal of the American Geriatrics Society, vol.335, issue.8, pp.1231-1236, 2006.
DOI : 10.1111/j.1532-5415.2006.00828.x

M. Cecile, V. Seux, V. Pauly, S. Tassy, O. Reynaud-levy et al., Accidents iatrog??nes m??dicamenteux chez le sujet ??g?? hospitalis?? en court s??jour g??riatrique??: ??tude de pr??valence et des facteurs de risques, La Revue de M??decine Interne, vol.30, issue.5, pp.393-400, 2009.
DOI : 10.1016/j.revmed.2009.01.010

N. Smith and . Pb, Temporal Trends in the Use of Anticoagulants Among Older Adults With Atrial Fibrillation, Archives of Internal Medicine, vol.159, issue.14, pp.1574-1578, 1999.
DOI : 10.1001/archinte.159.14.1574

C. Gross, E. Vogel, A. Dhond, C. Marple, R. Edwards et al., Factors influencing physicians' reported use of anticoagulation therapy in nonvalvular atrial fibrillation: A cross-sectional survey, Clinical Therapeutics, vol.25, issue.6, pp.1750-1764, 2003.
DOI : 10.1016/S0149-2918(03)80167-4

D. Pugh, J. Pugh, and G. Mead, Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review, Age and Ageing, vol.40, issue.6, pp.675-683, 2011.
DOI : 10.1093/ageing/afr097

A. Waldo, R. Becker, V. Tapson, K. Colgan, and . Nabor-steering-committee, Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation, Journal of the American College of Cardiology, vol.46, issue.9, pp.1729-1736, 2005.
DOI : 10.1016/j.jacc.2005.06.077

N. Choudhry, G. Anderson, A. Laupacis, D. Ross-degnan, S. Normand et al., Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis, BMJ, vol.332, issue.7534, pp.141-145, 2006.
DOI : 10.1136/bmj.38698.709572.55

B. Gage, E. Birman-deych, R. Kerzner, M. Radford, D. Nilasena et al., Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall, The American Journal of Medicine, vol.118, issue.6, pp.612-617, 2005.
DOI : 10.1016/j.amjmed.2005.02.022

M. Sellers and L. Newby, Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients, American Heart Journal, vol.161, issue.2, pp.241-246, 2011.
DOI : 10.1016/j.ahj.2010.11.002

L. Wann, A. Curtis, C. January, K. Ellenbogen, J. Lowe et al., AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) A Report of the American College of Cardiology Foundation, ACCFAmerican Heart Association Task Force on Practice Guidelines. Circulation. 1 avr, vol.123, issue.1, pp.104-123, 2011.

J. Cairns, S. Connolly, S. Mcmurtry, M. Stephenson, and M. Talajic, Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter, Canadian Journal of Cardiology, vol.27, issue.1, pp.74-90, 2011.
DOI : 10.1016/j.cjca.2010.11.007

G. Lip, L. Frison, J. Halperin, and D. Lane, Identifying Patients at High Risk for Stroke Despite Anticoagulation: A Comparison of Contemporary Stroke Risk Stratification Schemes in an Anticoagulated Atrial Fibrillation Cohort, Stroke, vol.41, issue.12, pp.2731-2738, 2010.
DOI : 10.1161/STROKEAHA.110.590257

B. Gage, A. Waterman, W. Shannon, M. Boechler, M. Rich et al., Validation of Clinical Classification Schemes for Predicting Stroke, JAMA, vol.285, issue.22, pp.2864-2870, 2001.
DOI : 10.1001/jama.285.22.2864

J. Olesen, G. Lip, M. Hansen, P. Hansen, J. Tolstrup et al., Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study, BMJ, vol.342, issue.jan31 1, p.124, 2011.
DOI : 10.1136/bmj.d124

G. Lip, R. Nieuwlaat, R. Pisters, D. Lane, and H. Crijns, Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach, Chest, vol.137, issue.2, pp.263-272, 2010.
DOI : 10.1378/chest.09-1584

V. Fuster, L. Rydén, D. Cannom, H. Crijns, A. Curtis et al., Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society, Circulation. 15 août, vol.114, issue.7, pp.257-354, 2006.

R. Nieuwlaat, A. Capucci, A. Camm, S. Olsson, D. Andresen et al., Atrial fibrillation management: a prospective survey in ESC Member Countries: The Euro Heart Survey on Atrial Fibrillation, European Heart Journal, vol.26, issue.22, pp.2422-2434, 2005.
DOI : 10.1093/eurheartj/ehi505

S. Apostolakis, D. Lane, Y. Guo, H. Buller, and G. Lip, Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk???Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation, Journal of the American College of Cardiology, vol.60, issue.9, pp.861-867, 2012.
DOI : 10.1016/j.jacc.2012.06.019

J. Olesen, G. Lip, P. Hansen, J. Lindhardsen, O. Ahlehoff et al., Bleeding risk in ???real world??? patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort, Journal of Thrombosis and Haemostasis, vol.120, issue.8, pp.1460-1467, 2011.
DOI : 10.1111/j.1538-7836.2011.04378.x

G. Lip, L. Frison, J. Halperin, and D. Lane, Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation, Journal of the American College of Cardiology, vol.57, issue.2, pp.173-180, 2011.
DOI : 10.1016/j.jacc.2010.09.024

M. Gehin, L. Kropka, A. Aubrège, M. Maignan, and J. De-korwin, R????valuation de l???indication de l???anticoagulation dans la fibrillation auriculaire ?? l???aide des scores de risque CHADS2??et HEMORR2HAGES. ??tude de faisabilit?? en soins primaires, La Revue de M??decine Interne, vol.31, p.466, 2010.
DOI : 10.1016/j.revmed.2010.10.274

W. Chumlea, A. Roche, and M. Steinbaugh, Estimating Stature from Knee Height for Persons 60 to 90 Years of Age, Journal of the American Geriatrics Society, vol.56, issue.2, pp.116-120, 1985.
DOI : 10.1111/j.1532-5415.1985.tb02276.x

S. Katz, T. Downs, H. Cash, and R. Grotz, Progress in development of the index of ADL. The Gerontologist, pp.20-30, 1970.

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

C. Derouesné, Au nom du groupe de recherche sur l'évaluation cognitive (GRECO)

D. Podsiadlo and S. Richardson, The Timed ???Up & Go???: A Test of Basic Functional Mobility for Frail Elderly Persons, Journal of the American Geriatrics Society, vol.68, issue.2, pp.142-148, 1991.
DOI : 10.1111/j.1532-5415.1991.tb01616.x

S. Mathias, U. Nayak, and B. Isaacs, Balance in elderly patients: the « get-up and go » test, Arch Phys Med Rehabil. juin, vol.67, issue.6, pp.387-389, 1986.

M. Miller and A. Towers, A manual of guidelines for scoring the cumulative illness rating scale for geriatrics (CIRS-G), 1991.

E. Waldman and J. Potter, A prospective evaluation of the cumulative illness rating scale, Aging Clinical and Experimental Research, vol.311, issue.2, pp.171-178, 1992.
DOI : 10.1007/BF03324087

F. Salvi, M. Miller, A. Grilli, R. Giorgi, A. Towers et al., A Manual of Guidelines to Score the Modified Cumulative Illness Rating Scale and Its Validation in Acute Hospitalized Elderly Patients, Journal of the American Geriatrics Society, vol.62, issue.10, pp.1926-1931, 2008.
DOI : 10.1111/j.1532-5415.2008.01935.x

B. Lesourd, F. Ziegler, and C. Aussel, La nutrition des personnes âgées : place et pièges du bilan biologique, Ann Biol Clin, vol.59, issue.4, pp.445-52, 2001.

M. Hughes and G. Lip, Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review, QJM, vol.100, issue.10, pp.599-607, 2007.
DOI : 10.1093/qjmed/hcm076

J. Vermeulen, J. Neyens, E. Van-rossum, M. Spreeuwenberg, and L. De-witte, Predicting ADL disability in community-dwelling elderly people using physical frailty indicators: a systematic review, BMC Geriatrics, vol.50, issue.1, p.33, 2011.
DOI : 10.1046/j.1532-5415.2002.50408.x

M. Maignan, L. Kropka, N. Jay, M. Gehin, A. Driad et al., Prise en compte du risque h??morragique pour le choix entre antivitamine K et antiplaquettaire dans la pr??vention des accidents thrombo-emboliques de la fibrillation auriculaire, La Revue de M??decine Interne, vol.32, p.180, 2011.
DOI : 10.1016/j.revmed.2011.03.306

N. Kagansky, H. Knobler, E. Rimon, Z. Ozer, and S. Levy, Safety of Anticoagulation Therapy in Well-informed Older Patients, Archives of Internal Medicine, vol.164, issue.18, pp.2044-2050, 2004.
DOI : 10.1001/archinte.164.18.2044

A. De-katz-hygiène-corporelle, Seul : 1point Avec aide : 0 point -Habillage : Seul : 1 point Avec aide : 0 point -Aller aux WC : Seul ou avec support technique : 1 point Avec aide humaine ou incapacité : 0 point -Continence : Contrôle complet : 1 point Incontinence urinaire et/ou fécale : 0 point -Locomotion : Déplacement seul ou avec support : 1 point Avec aide humaine, 1 point Avec aide, pp.0-0